Companies / IMR

IMRICOR MEDICAL SYSTEMS INC.

ASX:IMRHealth Care Equipment & Services
358.5M shares on issueASX (delayed) · as of 28 July 2026$2.00price · delayed$688.4Mmarket cap · indicative
D
Dilution grade

Share count grew 42% in 24 months; 5 cash raises in 24 months; options/rights overhang 111% of shares

Cash runway7.5 quarters of funding
Share-count growth (24m)42.1%
Raise cadence (24m)5 cash raises
Options & rights overhang111.4% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

IMRICOR MEDICAL SYSTEMS INC.'s ordinary share count grew 42.1% between July 2024 and July 2026, to 359M shares. The company raised capital five times in that 24-month window for total disclosed proceeds of A$190.2M, most recently a A$60.0M placement in April 2026. Options and rights on issue could convert into 399M new shares, equal to 111.4% of the current share count, with 0% in the money at present. At the March 2026 quarter the company reported A$61.8M in available cash, about 7.5 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
111.4%
Max option dilution
0.0%
ITM option dilution
2
Raises · last 12 months
7.5 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 358.5M per ASX (delayed) (28 July 2026).
288.7M314.4M340.0MDec 24Sept 25July 26Cash raise · 29 Apr 2026Cash raise · 29 Apr 2026Cash raise · 26 Mar 2025Cash raise · 14 Mar 2025Cash raise · 7 Feb 2025

Cash runway

7.5 qtrs
More than four quarters of funding at the recent spend rate.
$61.8M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
14 July 20263G · unquotedIMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB358.5MAppendix 3G
13 July 20262A · quoted issueIMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB358.5MAppendix 2A
20 May 20263G · unquotedIMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB353.5MAppendix 3G
20 May 20263H · cancellationIMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB353.5MAppendix 3H
19 May 20263G · unquotedIMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB353.5MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

5 cash raises in the last 24 months · 2 in the last 12 months

$60.0M
Placement
29 Apr 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

111.4%
Total overhang · of current shares
0.0%
In the money · at current price
399.4M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
14 May 2026Mr Peter McGregorOther———3Y notice
14 May 2026Mr Steve WedanOther—423k—3Y notice
14 May 2026Mr Aldo DentiOther23k——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

26 July 2026$PImricor Launches U.S. Commercial Operations
19 July 2026$PImricor Submits All Remaining 510(k) Devices to FDA
14 July 2026Notification regarding unquoted securities - IMR
13 July 2026Cleansing Notice
13 July 2026Application for quotation of securities - IMR
1 July 2026$PImricor Receives FDA Pediatric Clearances for iMR Device
25 June 2026Form S-8 Registration Statement
10 June 2026$PSubmission of the Third PMA Module to the US FDA for Review
26 May 2026Granting of ASX Waiver - US Financial Reporting Requirements
20 May 2026Notification of cessation of securities - IMR
20 May 2026Update - Notification regarding unquoted securities - IMR
19 May 2026Appendix 3Y - AD
19 May 2026Appendix 3Y - PM
19 May 2026Appendix 3Y - AM
19 May 2026Appendix 3Y - MT
19 May 2026Appendix 3Y - SW
19 May 2026Notification regarding unquoted securities - IMR
19 May 2026Becoming a substantial holder
17 May 2026Application for quotation of securities - IMR
17 May 2026Amendment to Form 10

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.